Genetics and molecular biology of intramedullary spinal cord tumors

Neurosurgery Clinics of North America

Volumn 17, Issue 1, 2006, Pages 1-5

  Chi, John H ^a   Cachola, Kristine ^a   Parsa, Andrew T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ASTROCYTOMA; DISEASE CLASSIFICATION; EPENDYMOMA; GENE MUTATION; GENETICS; GLIOBLASTOMA; HEMANGIOBLASTOMA; MOLECULAR BIOLOGY; NEUROFIBROMATOSIS; PRIORITY JOURNAL; REVIEW; SPINAL CORD TUMOR; VON HIPPEL LINDAU DISEASE;

ASTROCYTOMA; EPENDYMOMA; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; NEUROFIBROMATOSES; SPINAL CORD NEOPLASMS;

EID: 31544477108     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2005.10.002     Document Type: Review

References (32)

1. A. Parsa, T. Tihan, and P.C. McCormick Spinal axis tumors M. Berger M. Prados Textbook of neuro-oncology 2005 Elsevier Saunders Philadelphia 476 484
2. H.J. Gilhuis, J. van der Laak, and P. Wesseling Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox? J Neurooncol 66 2004 111 116
3. M. Santi, M. Quezado, and R. Ronchetti Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization J Neurooncol 72 2005 25 28
4. B.D. Birch, J.P. Johnson, and A. Parsa Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas Neurosurgery 39 1996 135 140
5. C. Ebert, M. von Haken, and B. Meyer-Puttlitz Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas Am J Pathol 155 1999 627 632
6. K. Lamszus, L. Lachenmayer, and U. Heinemann Molecular genetic alterations on chromosomes 11 and 22 in ependymomas Int J Cancer 91 2001 803 808
7. A.C. Ammerlaan, C. de Bustos, and A. Ararou Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray Genes Chromosomes Cancer 43 2005 329 338
8. T.J. Hulsebos, N.T. Oskam, and E.H. Bijleveld Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2 Br J Cancer 81 1999 1150 1154
9. B. Huang, P. Starostik, and H. Schraut Human ependymomas reveal frequent deletions on chromosomes 6 and 9 Acta Neuropathol (Berl) 106 2003 357 362
10. S. Scheil, S. Bruderlein, and M. Eicker Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization Brain Pathol 11 2001 133 143
11. A. Waha, A. Koch, and W. Hartmann Analysis of HIC-1 methylation and transcription in human ependymomas Int J Cancer 110 2004 542 549
12. E.K. Bijlsma, A.M. Voesten, and E.H. Bijleveld Molecular analysis of genetic changes in ependymomas Genes Chromosomes Cancer 13 1995 272 277
13. M.P. Rubio, K.M. Correa, and V. Ramesh Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas Cancer Res 54 1994 45 47
14. A. von Deimling, D.N. Louis, and O.D. Wiestler Molecular pathways in the formation of gliomas Glia 15 1995 328 338
15. W. Liu, C.D. James, and L. Frederick PTEN/MMAC1 mutations and EGFR amplification in glioblastomas Cancer Res 57 1997 5254 5257
16. R. Parsons Human cancer, PTEN and the PI-3 kinase pathway Semin Cell Dev Biol 15 2004 171 176
17. S. Glasker Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features Fam Cancer 4 2005 37 42
18. N. Kley, J. Whaley, and B.R. Seizinger Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function Glia 15 1995 297 307
19. W.Y. Kim, and W.G. Kaelin Role of VHL gene mutation in human cancer J Clin Oncol 22 2004 4991 5004
20. D. Glavac, H.P. Neumann, and C. Wittke Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe Hum Genet 98 1996 271 280
21. H.P. Neumann, C.J. Lips, and Y.E. Hsia von Hippel-Lindau syndrome Brain Pathol 5 1995 181 193
22. A.O. Vortmeyer, J.R. Gnarra, and M.R. Emmert-Buck von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease Hum Pathol 28 1997 540 543
23. S. Glasker, B.U. Bender, and T.W. Apel The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system J Neurol Neurosurg Psychiatry 67 1999 758 762
24. S. Glasker, B.U. Bender, and T.W. Apel Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system J Neurol Neurosurg Psychiatry 70 2001 644 648
25. M.E. Beckner, E. Sasatomi, and P.A. Swalsky Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13 Hum Pathol 35 2004 1105 1111
26. J.Y. Tse, J.H. Wong, and K.W. Lo Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas Am J Clin Pathol 107 1997 459 466
27. B.A. Ward, and D.H. Gutmann Neurofibromatosis 1: from lab bench to clinic Pediatr Neurol 32 2005 221 228
28. J.F. Gusella, V. Ramesh, and M. MacCollin Merlin: the neurofibromatosis 2 tumor suppressor Biochim Biophys Acta 1423 1999 M29 M36
29. L.B. Jacoby, M. MacCollin, and D.M. Parry Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis Neurogenetics 2 1999 101 108
30. M. Lee, A.R. Rezai, and D. Freed Intramedullary spinal cord tumors in neurofibromatosis Neurosurgery 38 1996 32 37
31. T. Yagi, K. Ohata, and M. Haque Intramedullary spinal cord tumour associated with neurofibromatosis type 1 Acta Neurochir (Wien) 139 1997 1055 1060
32. G. Dow, N. Biggs, and G. Evans Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history? J Neurosurg Spine 2 2005 574 579